10.1 Drugs used in rheumatic diseases and gout

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

1237 library items in 10.1 Drugs used in rheumatic diseases and gout

Filter results by:

Date Published

NeLM Area

Results filtered by:

Category

10: Musculoskeletal and joint diseases (remove) , 10.1 Drugs used in rheumatic diseases and gout (remove)

Sort by: Display summary:

Results 1 - 10 of 1237

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

Cohort study: Incidence of hospitalised bacterial infection associated with juvenile idiopathic arthritis and its treatment

Source: Arthritis and Rheumatism,
Date published: 14/05/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | Adverse Drug Reactions | Bacterial | Rheumatology

NeLM Area:

News

Abstract
2.

Horizon scanning: FDA advisory panel recommends approval of tofacitinib for adult patients with moderately to severely active rheumatoid arthritis

Source: PharmaLive,
Date published: 10/05/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | Food &Drug Administration (FDA) | Horizon scanning | Rheumatoid Arthritis

NeLM Area:

News

Link
3.

NHS Evidence’expert commentary: Acute and subacute neck pain

Source: NHS Evidence,
Date published: 10/05/2012

Category:

4.7.1 Non-opioid analgesics and compound analgesic preparations | 10.1.1 Non-steroidal anti-inflammatory drugs | Rheumatology

NeLM Area:

News

Link to registration page for Eyes on Evidence

Link to back copies of Eyes on Evidence
4.

FDA advisory panel rejects approval of rilonacept (Arcalyst®) injection for prevention of gout flares in patients initiating uric acid-lowering therapy

Source: BioSpace ,
Date published: 10/05/2012

Category:

10.1.4 Gout and cytotoxic-induced hyperuricaemia | Food &Drug Administration (FDA) | Gout | New drugs

NeLM Area:

News

Link
5.

Horizon scanning: Study suggests subcutaneous formulation of tocilizumab is of comparable efficacy to IV formulation

Source: BioSpace ,
Date published: 04/05/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | Drug Administration | Rheumatoid Arthritis

NeLM Area:

News

Link
6.

Improvement of the drug allergy alert for nonprescription NSAIDs

Source: Drug Information Journal,
Date published: 02/05/2012

Category:

10.1.1 Non-steroidal anti-inflammatory drugs | Adverse Drug Reactions | OTC medicines | Patient

NeLM Area:

Evidence > Medicines Management > References

Abstract link
7.

AWMSG issues Final Appraisal Recommendation on use of adalimumab (Humira®) for active polyarticular juvenile idiopathic arthritis

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 01/05/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | All Wales Medicines Strategy Group (AWMSG) | Paediatrics | Rheumatoid Arthritis

NeLM Area:

Evidence > Drug Specific Reviews

Link
8.

Final draft NICE guidance does not support the use of belimumab for treating SLE

Source: NICE,
Date published: 27/04/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | National Institute of Clinical Excellence (NICE) | Systemic Lupus Erythematosus

NeLM Area:

News

Final draft guidance (FAD)

Press release

Previous NeLM report on SMC guidance
9.

Should rheumatology patients on immunosuppressive medications be advised against getting tattoos?

Source: Irish Medical Journal,
Date published: 27/04/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process

NeLM Area:

Evidence > Medicines Management > References

Full text link
10.

Rituximab vs. second anti-TNF therapy for rheumatoid arthritis patients who have failed first anti-TNF: comparative analysis from BSR Biologics Register

Source: Arthritis Care Res ,
Date published: 26/04/2012

Category:

10.1.3 Drugs that suppress the rheumatic disease process | Rheumatoid Arthritis

NeLM Area:

News

Abstract

Results 1 - 10 of 1237

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next